ATE193725T1 - Anti-felincalicivirus rekombinanter antikörper und dafür kodierendes gen - Google Patents
Anti-felincalicivirus rekombinanter antikörper und dafür kodierendes genInfo
- Publication number
- ATE193725T1 ATE193725T1 AT93103066T AT93103066T ATE193725T1 AT E193725 T1 ATE193725 T1 AT E193725T1 AT 93103066 T AT93103066 T AT 93103066T AT 93103066 T AT93103066 T AT 93103066T AT E193725 T1 ATE193725 T1 AT E193725T1
- Authority
- AT
- Austria
- Prior art keywords
- antibody
- fcv
- feline
- recombinant antibody
- gene fragment
- Prior art date
Links
- 108090000623 proteins and genes Proteins 0.000 title abstract 5
- 241000714201 Feline calicivirus Species 0.000 abstract 4
- 239000012634 fragment Substances 0.000 abstract 3
- 241000282324 Felis Species 0.000 abstract 2
- 238000003745 diagnosis Methods 0.000 abstract 2
- 230000002265 prevention Effects 0.000 abstract 2
- 208000006339 Caliciviridae Infections Diseases 0.000 abstract 1
- 241000282326 Felis catus Species 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 229940126619 mouse monoclonal antibody Drugs 0.000 abstract 1
- 230000009870 specific binding Effects 0.000 abstract 1
- 230000009385 viral infection Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1036—Retroviridae, e.g. leukemia viruses
- C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- AIDS & HIV (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP7918992 | 1992-02-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE193725T1 true ATE193725T1 (de) | 2000-06-15 |
Family
ID=13683035
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT93103066T ATE193725T1 (de) | 1992-02-28 | 1993-02-26 | Anti-felincalicivirus rekombinanter antikörper und dafür kodierendes gen |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US5785968A (de) |
| EP (1) | EP0561194B1 (de) |
| AT (1) | ATE193725T1 (de) |
| AU (1) | AU661106B2 (de) |
| CA (1) | CA2090515C (de) |
| DE (1) | DE69328799T2 (de) |
| ES (1) | ES2149182T3 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004083390A2 (en) * | 2003-03-14 | 2004-09-30 | Regents Of The University Of California | Virulent systemic feline calicivirus |
| US7309495B2 (en) * | 2003-03-14 | 2007-12-18 | The Regents Of The University Of California | Hemorrhagic feline calicivirus |
| DE102011118031B4 (de) | 2011-06-23 | 2013-08-01 | Technische Universität Dresden | Calicivirus bindende Peptide, dafür kodierende Nukleinsäuren, deren Verwendungen und Verfahren und Kits zur Anreicherung, Immobilisierung und zum Nachweis von Caliciviren |
| US9901478B2 (en) | 2014-03-11 | 2018-02-27 | Chine, Llc | Methods and apparatuses for the external distraction in the assistance of spinal deformities |
| CN115141273B (zh) * | 2022-06-21 | 2024-02-06 | 泰州博莱得利生物科技有限公司 | 一种猫杯状病毒的单克隆抗体及其应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3937812A (en) * | 1974-11-21 | 1976-02-10 | Pitman-Moore, Inc. | Feline calicivirus vaccine and production thereof |
| US3944469A (en) * | 1974-11-21 | 1976-03-16 | Pitman-Moore, Inc. | Feline calicivirus vaccine and production thereof |
| GB8607679D0 (en) | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
| JPH01309785A (ja) | 1988-06-06 | 1989-12-14 | Babcock Hitachi Kk | ミドルパルスｔｉｇ溶接装置 |
| EP0484382B1 (de) * | 1989-07-21 | 1995-03-08 | The Upjohn Company | Felincalicivirus-capsid-protein und nukleotidsequenz |
| AU632843B2 (en) | 1989-08-10 | 1993-01-14 | Juridical Foundation The Chemo-Sero-Therapeutic Research Institute | Cat-mouse heterohybridoma and gene fragment coding for constant region of feline immunoglobulin |
-
1993
- 1993-02-26 AT AT93103066T patent/ATE193725T1/de not_active IP Right Cessation
- 1993-02-26 EP EP93103066A patent/EP0561194B1/de not_active Expired - Lifetime
- 1993-02-26 ES ES93103066T patent/ES2149182T3/es not_active Expired - Lifetime
- 1993-02-26 DE DE69328799T patent/DE69328799T2/de not_active Expired - Lifetime
- 1993-02-26 CA CA002090515A patent/CA2090515C/en not_active Expired - Fee Related
- 1993-02-26 AU AU33911/93A patent/AU661106B2/en not_active Ceased
- 1993-03-01 US US08/024,253 patent/US5785968A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| CA2090515C (en) | 2002-10-29 |
| DE69328799T2 (de) | 2000-10-26 |
| EP0561194A3 (en) | 1994-08-24 |
| DE69328799D1 (de) | 2000-07-13 |
| CA2090515A1 (en) | 1993-08-29 |
| AU3391193A (en) | 1993-09-02 |
| EP0561194A2 (de) | 1993-09-22 |
| AU661106B2 (en) | 1995-07-13 |
| EP0561194B1 (de) | 2000-06-07 |
| US5785968A (en) | 1998-07-28 |
| ES2149182T3 (es) | 2000-11-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE139900T1 (de) | Therapeutische verwendung von chimerischen und markierten antikörper gegen menschlichen b lymphozyt beschränkter differenzierung antigen für die behandlung von b-zell-lymphoma | |
| EP0671920A4 (de) | Ein anti-idiotypischer antikörper und seine verwendung in der diagnose und therapie von hiv-verwandten krankheiten. | |
| DE69535243D1 (de) | Gegen menschliches interleukin-8 gerichteter, rekonstituierter menschlicher antikörper | |
| DE69330031D1 (de) | Rekombinanter antikörper gerichtet gegen das feline herpesvirus-1 und dafür kodierendes genfragment | |
| DE3650753D1 (de) | Auf einmaligen sequenzen innerhalb des veränderlichen gebiets des t-zellrezeptors basierte diagnosemittel und deren verwendung | |
| NZ222309A (en) | Antibodies (including chimeric antibodies) to a human tumour antigen, polynucleotides encoding them, detection of the antigen by immunoassay and imaging methods and also cell killing methods | |
| DK121788A (da) | Il-6, fremgangsmaade til dets fremstilling samt dets anvendelse | |
| PT1005870E (pt) | Aplicação terapêutica de anticorpos quiméricos contra antigénio de diferenciação restrita de linfócitos b humanos, para o tratamento do linfoma de células b | |
| NO20014415D0 (no) | Medisinske preparater til behandling av <alfa>-galaktosidase- A-defisiens | |
| FI864016A (fi) | Med rekombinant-dna-teknik erhaollen kolonistimulerande faktor-1. | |
| DE3586841T2 (de) | Orale impfstoffe. | |
| BR9007702A (pt) | Metodo de tratamento | |
| ATE193725T1 (de) | Anti-felincalicivirus rekombinanter antikörper und dafür kodierendes gen | |
| DE68912155D1 (de) | Antivirales Kombinationspräparat. | |
| ATE125870T1 (de) | Hiv-spezifische monoklonale antikörper und hybridome zu ihrer herstellung. | |
| SE8404283L (sv) | Anvendning av ett specifikt tumorassocierat antigen, nemligen sialosyllaktotetraos, for diagnostiska och terapeutiska forfaranden vid cancersjukdomar | |
| FI853389A0 (fi) | Tumoerlaekemedel och foerfarande foer dess framstaellning. | |
| FI92716C (fi) | Uudet monoklonaaliset vasta-aineet IFN-omegalle, niiden valmistusmenetelmät ja niiden käyttö IFN-omegan puhdistamiseen ja osoittamiseen | |
| EP0248583A3 (en) | Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferon | |
| DE3751602D1 (de) | Subkutane Verabreichung des humanen Choriongonadotropins. | |
| DE3850933D1 (de) | Anticoagulatorisches Protein PP4-X, seine Herstellung und Verwendung. | |
| DE68918127D1 (de) | Peptidbehandlung von hartnäckigen Infektionskrankheiten. | |
| Khamitov | The state of cholinergic reactions of saliva and blood in patients with odontogenic osteomyelitis of the jaws | |
| Burnyasheva et al. | On the question of the treatment of urticaria | |
| JPS6471488A (en) | Preparation of human immunodeficient virus type i antigen, and its use as diagnostic and curing agents |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |